in Trinity College Dublin and post qualification he trained in internal
medicine and laboratory medicine. He has worked in the pharmaceutical industry
for 43 years and is experienced in drug development, regulatory affairs,
pharmacovigilance, quality assurance with extensive experience in risk
management, minimisation and avoidance.
He is a Staff
Grade Physician in the Beta Cell Centre in the Chelsea & Westminster NHS
Foundation Trust in London.
He has extensive
experience in drug development and has led teams in the successful development
of compounds from “First into Humans” to Phase III studies.
In the area of “Risk
Management” he has worked with small and large molecules including
h-erythropoietin, anti-rejection medicines in transplantation, thalidomide analogues
and bio-similar medicines. This has included presentations at scientific
meeting with clinical colleagues and medicines regulatory agencies which
includes the: FDA, EMA, National Agencies in Europe, Australia, Japan and South